Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

Updated April 9th, 2020

Heartburn Drug Zantac Must be Fully Removed From Shelves Because Of Cancer Risk, Says FDA

An impurity in the ingredient ranitidine has been found to increase cancer-risk over time. Find out what over-the-counter heartburn remedies you can safely take instead:

NOW
PLAYING
Understanding the Environment's Role in Cancer Risk -- Diet, Exposure & Genetics
NOW
PLAYING
Pfizer Issues New Nationwide Recall of Anti-Smoking Drug Chantix
NOW
PLAYING
Pfizer Recalls Anti-Smoking Drug Chantix Over Cancer Risk
NOW
PLAYING
Understanding the Relationship between IUDs and Cancer Risk
NOW
PLAYING
Pfizer Suspends Distribution of Anti-Smoking Drug Chantix Over Possible Cancer Risk
NOW
PLAYING
Iowa Woman Found Stage 2 Breast Cancer After Getting COVID-19 Shot: 'As Much as COVID Sucked, It Saved Me'

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.